Table 2

Migration from full to partial/no SMBG acquisition in 2009–2010 versus 2010–2011: propensity score–matched cohort

Beneficiaries, n (%)Mortality
n%
TEST: 2009–2010
Group:Migrating to:
Full insulin/full SMBG (n = 5,134)Full insulin/full SMBG3,962 (77.1)2957.4
Full insulin/partial or no SMBG1,181 (22.9)12810.8
P = 0.0002
NONTEST: 2009–2010
Group:Migrating to:
Full insulin/full SMBG (n = 4,947)Full insulin/full SMBG3,806 (76.9)2326.1
Full insulin/partial or no SMBG1,141 (23.1)1069.3
P = 0.0002
TEST: 2010–2011
Group:Migrating to:
Full insulin/full SMBG (n = 3,275)Full insulin/full SMBG2,112 (64.5)1336.3
Full insulin/partial or no SMBG1,163 (35.5)1028.8
P = 0.0087
NONTEST: 2010–2011
Group:Migrating to:
Full insulin/full SMBG (n = 3,100)Full insulin/full SMBG2,495 (80.5)1435.7
Full insulin/partial or no SMBG605 (19.5)609.9
P = 0.0002
  • A significantly higher percentage of TEST beneficiaries than NONTEST beneficiaries migrated from full to partial/no SMBG acquisition after implementation of the CBP.